Military Advisory Board

Mark W. Erwin

Co-Chair, Military Advisory Board

Erwin started his post education career in the US Army serving 26 years and culminating his career as Chief of Staff of the US Army Special Operations Command. He commanded at every level of the US Army’s 1st Special Forces Operational Detachment-Delta (Delta Force) from the rank of Captain to Colonel and was deployed Afghanistan, Iraq and other countries throughout the Middle East and Africa. From 2007 to 2009 he commanded a 3500-man Task Force responsible for hunting insurgents throughout Iraq.

Post military, Erwin learned business as CEO of a portfolio company for Fortress Investment Group enabling Medical Tourism in Africa and the Middle East. In 2014, he became President and owner of KGI, a risk advisory firm, which provides strategic consulting to Fortune 500 companies operating in emerging markets until he joined Bardstown Bourbon Company.

Erwin holds a degree in Psychology from Wake Forest University and conducted his War College Fellowship at the Central Intelligence Agency. Honors include induction into the US Army ROTC Hall of Fame and the Wake Forest University Sports Hall of Fame for Soccer.

← Team

US Customers

These products have not been evaluated or approved by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. In the United States, certain states permit the provision of certain stem cell therapies not approved by the FDA. Currently, the states of Florida, Georgia, Tennessee, and Utah, and Texas permit the provision of certain stem cell therapies, including Muse Cells, provided the various conditions of a particular state’s requirements are met. Any clinical use is at the sole discretion of a licensed healthcare provider and must comply with all applicable laws and regulations. Individual patient results may vary. No claims are made regarding safety or effectiveness for any specific clinical application.

Licensing & Trademark Integrity

As the global IP owner, MCI authorizes distribution only through approved partners who operate within a controlled, quality-assured framework. All legitimate Dezawa MuseCells® supplied to any market must originate from MCI’s manufacturing ecosystem and must be distributed through MCI-designated, licensed partners. This structure ensures that every Dezawa MuseCells® product regardless of country of delivery meets the highest scientific, ethical, and quality standards established by MCI and validated with ongoing global clinical research.

Legal Disclaimer

Dezawa High Performance™ does not promote or offer direct-to-consumer treatments. All clinical use of Dezawa MuseCells® must occur under licensed, ethics-reviewed, and jurisdictionally approved frameworks. This site is intended for institutional, clinical, and scientific audiences only. All published information utilizes Dezawa MuseCells® that are manufactured in accordance with MCI’s patented processes.